ATANIS Biotech serves over 20 institutional clients from pharma, biotech, and agri-food industries, providing services ranging from pre-clinical compound screening to efficacy assessment of selected drug candidates.
Company Description
ATANIS Biotech AG specializes in functional allergy diagnosis and has developed a novel, functional ex vivo mast cell activation test named FAST-PASE, which uses shelf-stable patient serum for scalability and has outperformed established clinical methods in diagnostic accuracy.